Gastrointestinal Disorder, Functional Clinical Trial
Official title:
Impact of Diet on Functional Gastrointestinal Symptoms; a National Population Based Survey
This cross-sectional survey study is to determine the prevalence of functional gastrointestinal (GI) disorders in the general population and to describe common triggers for food-related GI symptoms.
Functional gastrointestinal disorders, involving symptoms such as gas/bloating, diarrhea,
constipation and abdominal pain, are estimated to impact between 35 and 45 million Americans,
an overwhelming 15-20% of the population. These symptoms are responsible for upwards of 20
billion dollars in healthcare costs and extensive loss of quality of life for sufferers.
Moreover, many patients suffer in silence, with 67% of subjects waiting more than a year
before treatment, and 11% waiting over 10 years. Irritable bowel syndrome is the most
prevalent functional gastrointestinal disorder, and several recent studies support the idea
that dietary modifications may be key to alleviating this condition.
The purpose of this study is to document gastrointestinal symptoms among the US population,
as well as to ascertain awareness and utilization of dietary treatments that exist.
;
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT03269617 -
PHAGE Study: Bacteriophages as Novel Prebiotics
|
N/A | |
Terminated |
NCT02974686 -
Conversion From MPA to Zortress (Everolimus) for GI Toxicity Post-renal Transplantation
|
Phase 4 | |
Active, not recruiting |
NCT05363553 -
Transition to Infant Formula Feeding on Gastrointestinal Regurgitation (TIGER) Study
|
N/A | |
Completed |
NCT04530929 -
Analysis of the Impact of Used Probiotic Strains and Diet on Body Composition, Cardiopulmonary Efficiency and the Incidence of Gastrointestinal Disorders in Runners
|
N/A | |
Withdrawn |
NCT03014141 -
Effect of Oat Bran on Bowel Function and Appetite
|
N/A | |
Completed |
NCT05915767 -
Therapeutic Effect of Olive Leaf Tea on SIBO
|
N/A | |
Recruiting |
NCT03011151 -
Protease Activated Receptor-2 and Gastrointestinal Dysfunction in Critical Illness
|